144 related articles for article (PubMed ID: 16457144)
21. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.
Punt CJ; Nagy A; Douillard JY; Figer A; Skovsgaard T; Monson J; Barone C; Fountzilas G; Riess H; Moylan E; Jones D; Dethling J; Colman J; Coward L; MacGregor S
Lancet; 2002 Aug; 360(9334):671-7. PubMed ID: 12241873
[TBL] [Abstract][Full Text] [Related]
22. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group.
Kerr DJ; Gray R; McConkey C; Barnwell J
Ann Oncol; 2000 Aug; 11(8):947-55. PubMed ID: 11038030
[TBL] [Abstract][Full Text] [Related]
24. Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population-based study on 1547 patients.
Palazzi M; De Tomasi D; D'Affronto C; Richetti A; Valli MC; Meregalli S; Asnaghi D; Arienti V; Cavallini D; Pradella R; Cafaro I; Baroncelli G; Di Lorenzo I; De Agostini A; Parrinello G; Bertoni F
Tumori; 2002; 88(6):503-6. PubMed ID: 12597147
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
26. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy.
Pratt CB; Rao BN; Merchant TE; Shah A; Avery L; Cain A; Bodner S; Poquette C; Tan M
Med Pediatr Oncol; 1999 Jun; 32(6):459-60. PubMed ID: 10358711
[No Abstract] [Full Text] [Related]
27. Treatment and referral patterns for colorectal cancer.
Oliveria SA; Yood MU; Campbell UB; Yood SM; Stang P
Med Care; 2004 Sep; 42(9):901-6. PubMed ID: 15319616
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy and radiochemotherapy of colorectal cancers: adjuvant and palliative therapeutic procedures].
Porschen R; Bermann A
Leber Magen Darm; 1994 Jul; 24(4):164-9. PubMed ID: 7523820
[TBL] [Abstract][Full Text] [Related]
29. Choice of chemotherapy regimen for advanced colorectal cancer.
Summerhayes M
Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):520-1. PubMed ID: 12512977
[No Abstract] [Full Text] [Related]
30. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
31. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.
Bamias A; Basdanis G; Xanthakis I; Pavlidis N; Fountzilas G
Int J Gastrointest Cancer; 2005; 36(1):29-38. PubMed ID: 16227633
[TBL] [Abstract][Full Text] [Related]
33. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y
Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736
[TBL] [Abstract][Full Text] [Related]
34. Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: Can a regional intervention promote national change?
Taylor JC; Swinson D; Seligmann JF; Birch RJ; Dewdney A; Brown V; Dent J; Rossington HL; Quirke P; Morris EJA;
Int J Cancer; 2021 Feb; 148(4):845-856. PubMed ID: 32818319
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
36. [Colorectal cancer: what should be the management of primary tumour?].
Lelong B; Moutardier V; Delpero JR
Rev Prat; 2004 Jan; 54(2):155-66. PubMed ID: 15086058
[TBL] [Abstract][Full Text] [Related]
37. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.
Ramella S; Maranzano E; Frata P; Mantovani C; Lazzari G; Menichelli C; Navarria P; Pergolizzi S; Salvi F
Tumori; 2012; 98(1):66-78. PubMed ID: 22495704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
